Join us! UNC Lineberger’s annual scientific symposium: 15 talks on #PancreaticCancer  research, May 21 and 22. The event is free, virtual option available - register here: unclineberger.org/symposium/ UNC Pancreas Center @PanCan Lustgarten Foundation

PanCAN

The PROCLAIM Study is officially open to enrollment at affiliate site MCW Surgery and MCW LaBahn Pancreatic Cancer Program! So pleased to partner with Ugwuji Maduekwe and her team in this important work supported by Lustgarten Foundation 🤝👩‍🔬 Learn more about the trial:

clinicaltrials.gov/study/NCT06252…

Jaewon J. Lee presented at AHPBA and #ASA2024 in 24 hours and made it back to UNC Surgery to cover operating on a MBO the next day. #dedicated Yeh Lab Society of Surgical Oncology #CGSOFellows UNC Pancreas Center UNC Lineberger

check out Xianlu Laura Peng 🗣️DeCAF - fibroblast subtyping #pancreaticcancer #AACR24 Poster 6213 Section 36 Board 16 👇til 5 PM

For #UNC 's Justin Ashby, the mission to help pancreatic cancer patients is personal. Having lost his grandfather to the disease, the UNC School of Medicine student now works to develop new treatments at @unc_lineberger. 

Learn more about his research unc.live/3HTqOxk

We spoke with Mary Gillam a few times after her #PancreaticCancer diagnosis in 2017 & she, in turn, made herself available to others facing this disease. She was a gem, surviving until 2022. Her family continues her advocacy. “Run With Mary” benefits UNC Lineberger Cancer Center.

👏👏 to @YehLab and #GaryJohnson on a new R01 grant for their project, 'Targeting EGFR for basal subtype cancer.' Can EGFR inhibitors be retooled for basal subtype tumors to match #PancreaticCancer patients to effective 1st-line therapies? UNC Lineberger

rb.gy/vru839

We're PanCAN, of course we're here to support you through YOUR #pancreaticcancer journey. 💜 COMMENT down below and fill in the blank, 'We're the PanCAN community, of course we _______.' 💬

For Justin Ashby, cancer research holds a special place in his heart. After losing grandfather to pancreatic cancer, the @UNCSOM student knew he wanted to work in a lab focusing on new disease treatments.

Learn about his work with UNC Lineberger unc.live/3HTqOxk

Followed by Dr. Ashwin Somasundaram's insightful discussion of our efforts to improve #pancreaticcancer subtyping. Thanks to National Cancer Institute and Mayo Clinic for bringing together so many great minds this week.

Bravo to Bryant Lab UNC for a terrific presentation on autophagy inhibition in #pancreaticcancer National Cancer Institute SPORE Investigators Meeting 👏👏💜

Friday breaking news from Jonathan Wosen, Ph.D.
NIH panel calls for increasing postdoctoral fellowship salaries to $70,000 and capping the timeline for PDFs to five years.
Not set in concrete- these are recommendations at this point. The goal is to have fewer, better paid postdocs in…

So proud to have Justin as a member of our team 👏👏💜

Incredible work from Focal Medical, Inc. and Yeh Lab in developing their implantable drug delivery device for #PancreaticCancer . Clinical testing likely to begin summer 2024, can't wait to see what's in store for this promising technology! rb.gy/5s9k59

Big news! UNC Lineberger is now a site for a clinical trial testing two anti-cancer drugs in patients with localized unresectable #PancreaticCancer w/o progression after at least 16 weeks of first-line therapy. Learn more about the study:

cancer.gov/research/parti…

Thrilled that our new manuscript on Plasminogen in PDAC pathogenesis is out! Excellent work by Nayela N Chowdhury Yi Yang Ananya Dutta . Thanks to Alisa Wolberg Jim luyendyk Melissa Fishel and all who contributed. UNC Dept of Pathology and Laboratory Medicine UNC Pancreas Center febs.onlinelibrary.wiley.com/doi/epdf/10.10…